SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $537,000 | -14.4% | 75,410 | +0.3% | 0.00% | – |
| Q4 2021 | $627,000 | +64.6% | 75,220 | +122.9% | 0.00% | – |
| Q2 2017 | $381,000 | -14.8% | 33,744 | -14.9% | 0.00% | – |
| Q1 2017 | $447,000 | -8.6% | 39,640 | -0.4% | 0.00% | -100.0% |
| Q3 2016 | $489,000 | -84.5% | 39,804 | -63.4% | 0.00% | -75.0% |
| Q2 2016 | $3,163,000 | – | 108,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |